Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC
Clinical trial NCT07350824 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07350824
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-31
- Primary completion
- 2027-12-31
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.